Kaplan –Meier (3 A) and Cox-proportional hazard's (3 B) survival plots according to the three periods of ART initiation, Arba Minch Hospital, 2010.

<p>Kaplan –Meier (3 A) and Cox-proportional hazard's (3 B) survival plots according to the three periods of ART initiation, Arba Minch Hospital, 2010.</p

Survival curve according to Cox regression analysis after adjusting for disease stage, age and place of residence, Arba Minch Hospital, 2010

<p>. At about 48 weeks of pre-ART follow-up, about 25% of patients in the ‘early phase’ were not alive (See 2A). On the other hand, over 95% of those in the ‘rapid scale-up’ phase were alive at 48 weeks. Pre-ART loss to follow-up was less in the ‘early phase’ (See 2B).</p

Baseline characteristics of all treatment-naïve adult patients at enrollment, Arba Minch Hospital, 2010.

<p>Baseline characteristics of all treatment-naïve adult patients at enrollment, Arba Minch Hospital, 2010.</p

Hazard ratio (HR) for lost to follow up among patients on antiretroviral treatment at Arba Minch Hospital, 2010.

<p>CI =  Confidence Interval, HR =  Hazard ratio, Person Years of Observation.</p

Cohort profile, Arba Minch Hospital, 2010.

<p>Of 2391 patients enrolled for care, 2191 were eligible for analysis. At the end of the pre-ART follow-up period, 25% were not in care.</p

Hazard ratio (HR) for death among patients on antiretroviral treatment at Arba Minch Hospital, 2010.

<p>CI =  Confidence Interval, HR =  Hazard ratio, PYO =  Person Years of Observation.</p

WHO clinical stage at start of antiretroviral treatment at Arba Minch Hospital, 2010.

<p>Chi–square for trend (X² = 83.3; df  = 1; P<0.001).</p

Plot of responses to motivational survey items among participants from four regions of Ethiopia, April 15–May 10, 2018.

Plot of responses to motivational survey items among participants from four regions of Ethiopia, April 15–May 10, 2018.</p

Questionnaire used for data collection in ODK file was prepared in both local (Amharic) and English language.

(XLSX)</p

Motivation questions included in survey, source, and domain from April 15–May 10, 2018.

Motivation questions included in survey, source, and domain from April 15–May 10, 2018.</p